574 related articles for article (PubMed ID: 27172450)
1. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
Pind ML; Bendtsen F; Kallemose T; Møller S
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450
[TBL] [Abstract][Full Text] [Related]
2. Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease.
Møller S; la Cour Sibbesen E; Madsen JL; Bendtsen F
J Gastroenterol Hepatol; 2019 Jun; 34(6):1093-1099. PubMed ID: 30221390
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis.
Lisotti A; Azzaroli F; Buonfiglioli F; Montagnani M; Cecinato P; Turco L; Calvanese C; Simoni P; Guardigli M; Arena R; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G
Hepatology; 2014 Feb; 59(2):643-50. PubMed ID: 24038116
[TBL] [Abstract][Full Text] [Related]
4. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function.
Gu J; Zhang E; Liang B; Zhang Z; Chen X; Huang Z
World J Surg Oncol; 2020 Apr; 18(1):79. PubMed ID: 32326968
[TBL] [Abstract][Full Text] [Related]
6. Correlation Between Portal Pressure and Indocyanine Green Retention Rate is Unaffected by the Cause of Cirrhosis: A Prospective Study.
Kobayashi K; Uldry E; Kokudo T; Cristaudi A; Kawaguchi Y; Shirata C; Yamaguchi T; Dormond O; Duran R; Hasegawa K; Demartines N; Halkic N
World J Surg; 2021 Aug; 45(8):2546-2555. PubMed ID: 33891139
[TBL] [Abstract][Full Text] [Related]
7. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
[TBL] [Abstract][Full Text] [Related]
9. Liver reserve function assessment by acoustic radiation force impulse imaging.
Sun XL; Liang LW; Cao H; Men Q; Hou KZ; Chen Z; Zhao YE
World J Gastroenterol; 2015 Aug; 21(32):9648-55. PubMed ID: 26327773
[TBL] [Abstract][Full Text] [Related]
10. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
11. Indocyanine green retention is a potential prognostic indicator after splenectomy and pericardial devascularization for cirrhotic patients.
Zhang YB; Lu Y; Wu WD; Zhang CW; Shen GL; Hong dF
Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):386-90. PubMed ID: 27498578
[TBL] [Abstract][Full Text] [Related]
12. Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension.
Berzigotti A; Reverter E; García-Criado A; Abraldes JG; Cerini F; García-Pagán JC; Bosch J
J Hepatol; 2013 Oct; 59(4):717-22. PubMed ID: 23669282
[TBL] [Abstract][Full Text] [Related]
13. Correlation of baseline Portal pressure (hepatic venous pressure gradient) and Indocyanine Green Clearance Test With Post-transarterial Chemoembolization Acute Hepatic Failure.
Khisti R; Patidar Y; Garg L; Mukund A; Thomas SS; Sarin SK
J Clin Exp Hepatol; 2019; 9(4):447-452. PubMed ID: 31516260
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
[TBL] [Abstract][Full Text] [Related]
15. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.
Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO
Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641
[TBL] [Abstract][Full Text] [Related]
17. TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes.
Busk TM; Bendtsen F; Nielsen HJ; Jensen V; Brünner N; Møller S
Scand J Gastroenterol; 2014 Sep; 49(9):1103-10. PubMed ID: 25048331
[TBL] [Abstract][Full Text] [Related]
18. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma.
Wang YY; Zhao XH; Ma L; Ye JZ; Wu FX; Tang J; You XM; Xiang BD; Li LQ
J Surg Oncol; 2018 Sep; 118(3):440-445. PubMed ID: 30259515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]